Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis

Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis

Abstract Background To identify the most cost-beneficial model as a national policy of screening and diagnosis of fetal Down syndrome (DS) in developing countries. Methods Cost-benefit analysis (CBA) was performed based on the effectiveness and probabilities derived from a large prospective study on...

Full description

Bibliographic Details
Main Authors: Chanane Wanapirak, Piyaluk Buddhawongsa, Woraluck Himakalasa, Auttapan Sarnwong, Theera Tongsong
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Health Services Research
Subjects:
Down syndrome
Prenatal screening
Prenatal diagnosis
Cost-benefit
Developing country
Online Access:http://link.springer.com/article/10.1186/s12913-019-4699-4

Internet

http://link.springer.com/article/10.1186/s12913-019-4699-4

Similar Items